← Browse by Condition
Medical Condition

transformed b cell lymphoma unclassifiable with features intermediate between diffuse large b cell lymphoma and classic hodgkin lymphoma to diffuse large b ce

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07097363 Phase 2
Recruiting

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

Enrollment
18 pts
Location
United States
Sponsor
University of Washington
View Trial →